ConductScience.org, home

Paper971945

Lysis of Acholeplasma laidlawii by antibodies and complement.

Brunner H and 4 others. Infect Immun, 1976. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Lysis of Acholeplasma laidlawii by antibodies and complement. Papers, record 971945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/971945

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lysis of Acholeplasma laidlawii by antibodies and complement.
PubMed
Journal
Infect Immun
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brunner HH
2Dörner II
3Schiefer HGH G
4Krauss HH
5Wellensiek HJH J

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acholeplasma laidlawiiMajor topic
Antibodies, BacterialMajor topic
Complement System ProteinsMajor topic
Acholeplasma
Cell Membrane
Microscopy, Electron

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113,851,485Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes.J Exp Med1959https://conductscience.org/library/papers/13851485PubMed
213,878,126Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.Proc Natl Acad Sci U S A1962https://conductscience.org/library/papers/13878126PubMed
461,175Complement-mediated killing of Acholeplasma laidlawii by antibodies to various membrane components.Infect Immun1976https://conductscience.org/library/papers/61175PubMed
54,174,135Chemistry and reaction mechanisms of complement.Adv Immunol1968https://conductscience.org/library/papers/4174135PubMed
64,117,012Mechanism of cytolysis by complement.Proc Natl Acad Sci U S A1972https://conductscience.org/library/papers/4117012PubMed
74,346,598Studies on the terminal stages of complement lysis.Immunology1973https://conductscience.org/library/papers/4346598PubMed
84,572,613Ultrastructural lesions in Mycoplasma pneumoniae membranes produced by antibody and complement.Infect Immun1973https://conductscience.org/library/papers/4572613PubMed
94,554,562Antibody-complement interaction with lipid model membranes.Biochim Biophys Acta1972https://conductscience.org/library/papers/4554562PubMed
105,058,233Molecular analysis of the membrane attack mechanism of complement.J Exp Med1972https://conductscience.org/library/papers/5058233PubMed
114,908,393The lesions in cell membranes caused by complement.Adv Immunol1969https://conductscience.org/library/papers/4908393PubMed
125,332,190Interaction of polyene antibiotics with natural and artificial membrane systems.Fed Proc1966https://conductscience.org/library/papers/5332190PubMed
135,246,926Immune response of a liposomal model membrane.Proc Natl Acad Sci U S A1968https://conductscience.org/library/papers/5246926PubMed
145,539,640Production of ultrastructural membrane lesions by the fifth component of complement.J Exp Med1971https://conductscience.org/library/papers/5539640PubMed
155,482,273Fate of phospholipids in liposomal model membranes damaged by antibody and complement.Biochemistry1970https://conductscience.org/library/papers/5482273PubMed
165,417,177The relationship between fatty acid structure and the positional distribution of esterified fatty acids in phosphatidyl glycerol from Mycoplasma laidlawii B.Biochim Biophys Acta1970https://conductscience.org/library/papers/5417177PubMed
175,795,461Immunochemical analysis of Mycoplasma pneumoniae. 3. Separation and chemical identification of serologically active lipids.Aust J Exp Biol Med Sci1969https://conductscience.org/library/papers/5795461PubMed
185,777,213Mycoplasma membrane lipids: variations in fatty acid composition.Science1969https://conductscience.org/library/papers/5777213PubMed
195,643,073Serum complement and the enzymatic degradation of erythrocyte phospholipid.J Immunol1968https://conductscience.org/library/papers/5643073PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
6,249,263Complement-mediated production of plasma-membrane vesicles from rat fat-cells.Biochem J1980https://conductscience.org/library/papers/6249263PubMed
908,614Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum.Infect Immun1977https://conductscience.org/library/papers/908614PubMed
641,139Increased fluidity of human platelet membranes during complement-mediated immune platelet injury.J Clin Invest1978https://conductscience.org/library/papers/641139PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/971945

GET https://conductscience.org/api/papers/v1/971945/authors